We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Noted for its ability to provide ‘great strategic advice’ and its determination ’to leave no stone unturned’, Stephenson Harwood excels in multi-jurisdictional litigation, handling complex mandates for strong players in the pharmaceutical and biotech sectors. Leading the team is Alexandra Pygall, who draws on her background in chemistry to provide technical advice to a litany of clients. Another name to note in the practice is Rob Jacob, who is highly experienced on the contentious front, as well as Naomi Leach, who strengthens the team’s transactional capabilities. Helen Conlan, who joined from Mishcon de Reya LLP in November 2023, principally focuses on patent litigation in the technology sector. Peter Dalton returned to Herbert Smith Freehills Kramer LLP in the same month.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Alexandra Pygall is an exceptionally talented IP lawyer who tirelessly works to ensure a great result for her clients. She has considerable knowledge in all areas of IP law.'
‘A good all-round IP team, strengthened in patent litigation by Helen Conlan recently joining it.’
Key clients
- GlaxoSmithKline Plc
- Haleon Plc
Work highlights
Advised BenevolentAI on its strategic collaboration with Merck to utilise BenevolentAI’s end-to-end AI platform capabilities to deliver novel drug candidates, initially for three targets in oncology, neurology, and immunology.
Advised Bicycle Therapeutics in parallel on two complex collaboration agreements with Novartis and Bayer respectively to utilise Bicycle's platform to discover and develop novel targeted radionuclide therapies.